Principles of pharmacogenetics and pharmacogenomics

著者

書誌事項

Principles of pharmacogenetics and pharmacogenomics

edited by Russ B. Altman, David Flockhart, David B. Goldstein

Cambridge University Press, 2012

大学図書館所蔵 件 / 全3件

この図書・雑誌をさがす

注記

Includes bibliographical references

内容説明・目次

内容説明

The study of pharmacogenetics and pharmacogenomics focuses on how our genes and complex gene systems influence our response to drugs. Recent progress in clinical therapeutics has led to the discovery of new biomarkers that make it technically easier to identify groups of patients which are more or less likely to respond to individual therapies. The aim is to improve personalised medicine - not simply to prescribe the right medicine, but to deliver the right drug at the right dose at the right time. This textbook brings together leading experts to discuss the latest information on how human genetics impacts drug response phenotypes. It presents not only the basic principles of pharmacogenetics, but also clinically valuable examples that cover a broad range of specialties and therapeutic areas. This textbook is an invaluable introduction to pharmacogenetics and pharmacogenomics for health care professionals, medical students, pharmacy students, graduate students and researchers in the biosciences.

目次

  • Introduction to population diversity and genetic testing: basic concepts Russ Altman, David Flockhart and David Goldstein
  • Part I. Critical Concepts: 1. Introduction to population diversity and genetic testing James K. Burmester, Ingrid Glurich, Kimberly Pillsbury and Michael D. Caldwell
  • 2. Genotyping technologies Sharon Marsh and Cristi R. King
  • 3. Pharmacokinetics: absorption, distribution, metabolism, excretion Terry Blaschke
  • 4. Overview: adverse drug reactions Matthew Nelson
  • 5. PharmGKB, a centralized resource for pharmacogenomic knowledge and discovery Li Gong and Teri E. Klein
  • 6. DrugBank David S. Wishart
  • 7. Ethical considerations for pharmacogenomics: privacy and confidentiality Sandra Lee
  • 8. Informed consent in pharmacogenomic research and treatment Mark Rothstein
  • 9. Legal trends driving the clinical translation of pharmacogenomics Barbara Evans
  • Part II. Therapeutic Areas: 10. Pharmacogenetics of oncologic drugs Uchenna Njaju and Eileen Dolan
  • 11. Pharmacogenetics of cardiovascular drugs Michael Stein and Danny Kurnik
  • 12. Pharmacogenomics of statin-induced muscle toxicity Ronald M. Krauss, Russell A. Wilke, Melissa Antonik and Elenita Kanin
  • 13. Pharmacogenomics of the drug-induced long QT syndrome Dan M. Roden, Prince J. Kannankeril, Stefan Kaab and Dawood Darbar
  • 14. Pharmacogenetics of diabetes drugs O. H. Klungel and Mark C. H. DeGroot
  • 15. Pharmacogenetics of respiratory drugs Kelan Tantisira and Scott Weiss
  • 16. Pharmacogenomics for acid-related gastrointestinal drugs Takahisa Furuta
  • 17. Pharmacogenetics of rheumatoid arthritis drugs Robert M. Plenge, Yvonne C. Lee, Souomya Raychaudhuri and Daniel H. Solomon
  • 18. Pharmacogenomics of obstetric drugs David Haas and Jamie Renbarger
  • 19. Pharmacogenomics of psychiatric drugs David Mrazek
  • 20. Pharmacogenomics of pain and anesthesia drugs Evan Kharasch and Konrad Meissner
  • 21. Pharmacogenetics of HIV and antiretroviral drugs Amalio Telenti
  • 22. Pharmacogenomics in pediatrics Jennifer A. Lowry and J. Steven Leeder
  • 23. Pharmacogenomics in fetal and neonatal medicine Yair Blumenfeld.

「Nielsen BookData」 より

詳細情報

ページトップへ